Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting, 25251-25252 [2024-07521]

Download as PDF Federal Register / Vol. 89, No. 70 / Wednesday, April 10, 2024 / Notices be collected; and (d) Minimize the reporting burden on those who are to respond, including the use of automated collection techniques or other forms of information technology. Comments that you submit in response to this notice are a matter of public record. We will include or summarize each comment in our request to OMB to approve this ICR. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you may ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Sheleen Dumas, Department PRA Clearance Officer, Office of the Under Secretary for Economic Affairs, Commerce Department. [FR Doc. 2024–07627 Filed 4–9–24; 8:45 am] BILLING CODE 3510–22–P DEPARTMENT OF COMMERCE National Oceanic and Atmospheric Administration ddrumheller on DSK120RN23PROD with NOTICES1 Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Weather Modification Activities Reports The Department of Commerce will submit the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995, on or after the date of publication of this notice. We invite the general public and other Federal agencies to comment on proposed, and continuing information collections, which helps us assess the impact of our information collection requirements and minimize the public’s reporting burden. Public comments were previously requested via the Federal Register on 2 January 2024 during a 60-day comment period. This notice allows for an additional 30 days for public comments. Agency: National Oceanic & Atmospheric Administration, Commerce. Title: Weather Modification Activities Reports. OMB Control Number: 0648–0025. Form Number(s): NOAA Forms 17–4 and 17–4A. VerDate Sep<11>2014 18:10 Apr 09, 2024 Jkt 262001 Type of Request: Regular submission (extension of a current information collection). Number of Respondents: 30. Average Hours per Response: 60 minutes per initial report; approximately 10 cases involve interim reports; 30 minutes per interim or final report. Total Annual Burden Hours: 50 hours. Needs and Uses: The National Oceanic & Atmospheric Administration’s Office of Atmospheric Research (OAR)/Weather Program Office is conducting this information collection pursuant to section 6(b) of Public Law 92–205. This law requires that all non-Federal weather modification activities (e.g., cloud seeding) in the United States (U.S.) and its territories be reported to the Secretary of Commerce through NOAA. This reporting is critical for gauging the scope of these activities, for determining the possibility of duplicative operations or of interference with another project, for providing a database for checking atmospheric changes against the reported activities, and for providing a single source of information on the safety and environmental factors used in weather modification activities in the U.S. Two forms are collected under this OMB Control Number: one prior to and one after the activity. The requirements are detailed in 15 CFR part 908. This data is used for scientific research, historical statistics, international reports and other purposes. Affected Public: Business or other forprofit organizations. Frequency: On occasion (Beginning and end of projects). Respondent’s Obligation: Mandatory. Legal Authority: Public Law 92–205, Weather Modification Reporting Act of 1972. This information collection request may be viewed at www.reginfo.gov. Follow the instructions to view the Department of Commerce collections currently under review by OMB. Written comments and recommendations for the proposed information collection should be submitted within 30 days of the publication of this notice on the following website www.reginfo.gov/ public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function and PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 25251 entering either the title of the collection or the OMB Control Number 0648–0025. Sheleen Dumas, Department PRA Clearance Officer, Office of the Under Secretary for Economic Affairs, Commerce Department. [FR Doc. 2024–07583 Filed 4–9–24; 8:45 am] BILLING CODE 3510–KD–P DEPARTMENT OF DEFENSE Office of the Secretary Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting Under Secretary of Defense for Personnel and Readiness, Department of Defense (DoD). ACTION: Notice of Federal advisory committee meeting. AGENCY: The DoD is publishing this notice to announce that the following Federal advisory committee meeting of the Uniform Formulary Beneficiary Advisory Panel (UFBAP) was held on Wednesday, April 3, 2024. DATES: Open to the public Wednesday, April 3, 2024, from 10:00 a.m. to 1:00 p.m. eastern standard time. ADDRESSES: The meeting was held telephonically or via conference call. The phone number for the remote access on April 3, 2024, was CONUS: 1–888– 831–4306; OCONUS: 1–210–234–8694; PARTICIPANT CODE: 9136304. These numbers and the dial-in instructions were posted on the UFBAP website at: https://www.health.mil/ Military-Health-Topics/Access-CostQuality-and-Safety/PharmacyOperations/BAP. FOR FURTHER INFORMATION CONTACT: Designated Federal Officer (DFO) Colonel (COL) Paul B. Carby, USA, 703– 681–2890 (voice), dha.ncr.j6.mbx.baprequests@health.mil (email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Website: https:// www.health.mil/Military-Health-Topics/ Access-Cost-Quality-and-Safety/ Pharmacy-Operations/BAP. The most up-to-date changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of the DFO, the UFBAP was unable to provide public notification required by 41 CFR 102–3.150(a) concerning its April 3, 2024 meeting. Accordingly, the Advisory Committee Management Officer for the DoD, pursuant to 41 CFR 102–3.150(b), waives the 15-calendar day notification requirement. SUMMARY: E:\FR\FM\10APN1.SGM 10APN1 ddrumheller on DSK120RN23PROD with NOTICES1 25252 Federal Register / Vol. 89, No. 70 / Wednesday, April 10, 2024 / Notices This meeting was held under the provisions of chapter 10 of title 5 United States Code (U.S.C.) (commonly known as the ‘‘Federal Advisory Committee Act’’ or ‘‘FACA’’), 5 U.S.C. 552b (commonly known as the ‘‘Government in the Sunshine Act’’) and 41 CFR 102– 3.140 and 102–3.150. Purpose of the Meeting: The UFBAP reviewed and commented on recommendations made by the Pharmacy and Therapeutics Committee to the Director, Defense Health Agency regarding the Uniform Formulary. Agenda: 1. 10:00 a.m.–10:10 a.m. Sign In for UFBAP members 2. 10:10 a.m.–10:40 a.m. Welcome and Opening Remarks a. Welcome, Opening Remarks, and Introduction of UFBAP Members by COL Paul B. Carby, DFO, UFBAP b. Public Written Comments by COL Paul B. Carby, DFO, UFBAP c. Opening Remarks by Mr. Jon Ostrowski, UFBAP Chair d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary Management Branch 3. 10:40 a.m.–11:45 a.m. Scheduled Therapeutic Class Reviews 4. 11:45 a.m.–12:30 p.m. Newly Approved Drugs Review 5. 12:30 p.m.–12:45 p.m. Pertinent Utilization Management Issues 6. 12:45 p.m.–1:00 p.m. Closing remarks a. Closing Remarks by UFBAP CoChair b. Closing Remarks by DFO, UFBAP Meeting Accessibility: Pursuant to 5 U.S.C. 1009(a)(1) and 41 CFR 102–3.140 through 102–3.165, and subject to the availability of phone lines, this meeting was open to the public. Telephone lines were limited and available to the first 220 people dialing in. There were 220 lines total: 200 domestic and 20 international, including leader lines. Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140(c), and 5 U.S.C. 1009(a)(3), interested persons or organizations may submit written statements to the UFBAP about its mission and/or the agenda to be addressed in this public meeting. Written statements should be submitted to the UFBAP’s DFO. The DFO’s contact information can be found in the FOR FURTHER INFORMATION CONTACT section of this notice. Written comments or statements must be received by the UFBAP’s DFO so they may be made available to the UFBAP for its consideration. Written comments received are releasable to the public. The DFO will review all submitted written statements and provide copies to UFBAP. VerDate Sep<11>2014 18:10 Apr 09, 2024 Jkt 262001 Dated: April 3, 2024. Aaron T. Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2024–07521 Filed 4–9–24; 8:45 am] BILLING CODE 6001–FR–P DEPARTMENT OF EDUCATION [Docket No.: ED–2024–SCC–0056] Agency Information Collection Activities; Comment Request; Assurance of Compliance—Civil Rights Certificate Office for Civil Rights (OCR), Department of Education (ED). ACTION: Notice. AGENCY: In accordance with the Paperwork Reduction Act (PRA) of 1995, the Department is proposing an extension without change of a currently approved information collection request (ICR). DATES: Interested persons are invited to submit comments on or before June 10, 2024. ADDRESSES: To access and review all the documents related to the information collection listed in this notice, please use https://www.regulations.gov by searching the Docket ID number ED– 2024–SCC–0056. Comments submitted in response to this notice should be submitted electronically through the Federal eRulemaking Portal at https:// www.regulations.gov by selecting the Docket ID number or via postal mail, commercial delivery, or hand delivery. If the regulations.gov site is not available to the public for any reason, the Department will temporarily accept comments at ICDocketMgr@ed.gov. Please include the docket ID number and the title of the information collection request when requesting documents or submitting comments. Please note that comments submitted after the comment period will not be accepted. Written requests for information or comments submitted by postal mail or delivery should be addressed to the Manager of the Strategic Collections and Clearance Governance and Strategy Division, U.S. Department of Education, 400 Maryland Ave. SW, LBJ, Room 6W203, Washington, DC 20202–8240. FOR FURTHER INFORMATION CONTACT: For specific questions related to collection activities, please contact Elizabeth Wiegman, (202) 987–1347. SUPPLEMENTARY INFORMATION: The Department, in accordance with the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3506(c)(2)(A)), provides the SUMMARY: PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 general public and Federal agencies with an opportunity to comment on proposed, revised, and continuing collections of information. This helps the Department assess the impact of its information collection requirements and minimize the public’s reporting burden. It also helps the public understand the Department’s information collection requirements and provide the requested data in the desired format. The Department is soliciting comments on the proposed information collection request (ICR) that is described below. The Department is especially interested in public comment addressing the following issues: (1) is this collection necessary to the proper functions of the Department; (2) will this information be processed and used in a timely manner; (3) is the estimate of burden accurate; (4) how might the Department enhance the quality, utility, and clarity of the information to be collected; and (5) how might the Department minimize the burden of this collection on the respondents, including through the use of information technology. Please note that written comments received in response to this notice will be considered public records. Title of Collection: Assurance of Compliance—Civil Rights Certificate. OMB Control Number: 1870–0503. Type of Review: Extension without change of a currently approved ICR. Respondents/Affected Public: State, Local, and Tribal Governments; Private Sector. Total Estimated Number of Annual Responses: 25. Total Estimated Number of Annual Burden Hours: 8. Abstract: The Office for Civil Rights (OCR) has enforcement responsibilities under several civil rights laws, including title VI of the Civil Rights Act of 1964, title IX of the Education Amendments of 1972, section 504 of the Rehabilitation Act of 1973, the Age Discrimination Act of 1975, and the Boy Scouts of America Equal Access Act. To meet these responsibilities, OCR collects assurances of compliance from applicants for Federal financial assistance from, and applicants for funds made available through, the Department of Education, as required by regulations. These entities include, for example, State educational agencies, local education agencies, and postsecondary educational institutions. If a recipient violates one or more of these civil rights laws, OCR and the Department of Justice can use the signed assurances of compliance in an enforcement proceeding. E:\FR\FM\10APN1.SGM 10APN1

Agencies

[Federal Register Volume 89, Number 70 (Wednesday, April 10, 2024)]
[Notices]
[Pages 25251-25252]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07521]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meeting

AGENCY: Under Secretary of Defense for Personnel and Readiness, 
Department of Defense (DoD).

ACTION:  Notice of Federal advisory committee meeting.

-----------------------------------------------------------------------

SUMMARY: The DoD is publishing this notice to announce that the 
following Federal advisory committee meeting of the Uniform Formulary 
Beneficiary Advisory Panel (UFBAP) was held on Wednesday, April 3, 
2024.

DATES:  Open to the public Wednesday, April 3, 2024, from 10:00 a.m. to 
1:00 p.m. eastern standard time.

ADDRESSES:  The meeting was held telephonically or via conference call. 
The phone number for the remote access on April 3, 2024, was CONUS: 1-
888-831-4306; OCONUS: 1-210-234-8694; PARTICIPANT CODE: 9136304.
    These numbers and the dial-in instructions were posted on the UFBAP 
website at: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP.

FOR FURTHER INFORMATION CONTACT:  Designated Federal Officer (DFO) 
Colonel (COL) Paul B. Carby, USA, 703-681-2890 (voice), [email protected] (email). Mailing address is 7700 Arlington 
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP. The most up-to-date changes to the meeting 
agenda can be found on the website.

SUPPLEMENTARY INFORMATION:  Due to circumstances beyond the control of 
the DFO, the UFBAP was unable to provide public notification required 
by 41 CFR 102-3.150(a) concerning its April 3, 2024 meeting. 
Accordingly, the Advisory Committee Management Officer for the DoD, 
pursuant to 41 CFR 102-3.150(b), waives the 15-calendar day 
notification requirement.

[[Page 25252]]

    This meeting was held under the provisions of chapter 10 of title 5 
United States Code (U.S.C.) (commonly known as the ``Federal Advisory 
Committee Act'' or ``FACA''), 5 U.S.C. 552b (commonly known as the 
``Government in the Sunshine Act'') and 41 CFR 102-3.140 and 102-3.150.
    Purpose of the Meeting: The UFBAP reviewed and commented on 
recommendations made by the Pharmacy and Therapeutics Committee to the 
Director, Defense Health Agency regarding the Uniform Formulary.
    Agenda:

1. 10:00 a.m.-10:10 a.m. Sign In for UFBAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
    a. Welcome, Opening Remarks, and Introduction of UFBAP Members by 
COL Paul B. Carby, DFO, UFBAP
    b. Public Written Comments by COL Paul B. Carby, DFO, UFBAP
    c. Opening Remarks by Mr. Jon Ostrowski, UFBAP Chair
    d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary 
Management Branch
3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews
4. 11:45 a.m.-12:30 p.m. Newly Approved Drugs Review
5. 12:30 p.m.-12:45 p.m. Pertinent Utilization Management Issues
6. 12:45 p.m.-1:00 p.m. Closing remarks
    a. Closing Remarks by UFBAP Co-Chair
    b. Closing Remarks by DFO, UFBAP

    Meeting Accessibility: Pursuant to 5 U.S.C. 1009(a)(1) and 41 CFR 
102-3.140 through 102-3.165, and subject to the availability of phone 
lines, this meeting was open to the public. Telephone lines were 
limited and available to the first 220 people dialing in. There were 
220 lines total: 200 domestic and 20 international, including leader 
lines.
    Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-
3.140(c), and 5 U.S.C. 1009(a)(3), interested persons or organizations 
may submit written statements to the UFBAP about its mission and/or the 
agenda to be addressed in this public meeting. Written statements 
should be submitted to the UFBAP's DFO. The DFO's contact information 
can be found in the FOR FURTHER INFORMATION CONTACT section of this 
notice. Written comments or statements must be received by the UFBAP's 
DFO so they may be made available to the UFBAP for its consideration. 
Written comments received are releasable to the public. The DFO will 
review all submitted written statements and provide copies to UFBAP.

    Dated: April 3, 2024.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2024-07521 Filed 4-9-24; 8:45 am]
BILLING CODE 6001-FR-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.